BMJ Open Diabetes Research & Care is a high-quality source for basic and clinical research regarding type 1 and type 2 diabetes, and associated complications. A rapid review process — and continuous online updates — ensure the publication of timely research.

  • High quality
  • Open Access
  • Original Research
  • Peer reviewed

Published by BMJ in partnership with the American Diabetes Association.

Editor's Choice

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Glucagon-like peptide-1 (GLP-1) receptor activation delays the progression of diabetic nephropathy (DN) in rodents. The NOD-like receptor 3 (Nlrp3) inflammasome plays an important role in DN.
Read this free article chosen by the Editor >>

Content Alerts

Receive the latest table of contents via email. Be the first to download breakthrough articles.

Register here >>

Submit

BMJ Open Diabetes Research & Care welcomes high-quality submissions. Article Publishing Charges may apply.

Online submission >>
Instructions for authors >>
Article Publishing Charge >>

PubMed and Scopus Indexed

BMJ Open Diabetes Research & Care articles are now discoverable via PubMed and PubMed Central and in Scopus.

View the Archive >>

In the news

See where BMJ Open Diabetes Research & Care has been mentioned in the media and read stories that cite its published articles.

Click here >>

Most read

See what your colleagues are reading and stay informed on the latest advances in diabetes research and treatment.

Most read >>